Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Long-Term Debt, Due in More Than 1 Year: Other Long-Term Loans
QFRD319385USNO • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
486,687.00
Year-over-Year Change
7.45%
Date Range
10/1/2000 - 4/1/2025
Summary
This economic indicator tracks long-term debt for pharmaceutical and medicine corporations in the United States, specifically focusing on loans due beyond one year. The metric provides critical insights into the financial leverage and borrowing strategies of a key sector in the U.S. economy.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
The trend represents the aggregate long-term debt obligations of pharmaceutical and medicine corporations, excluding standard debt instruments like bonds. Economists use this data to assess sector-specific financial health, investment capacity, and potential risk exposure.
Methodology
Data is collected through quarterly financial reports submitted by corporations in the pharmaceutical and medicine manufacturing sectors, compiled and standardized by federal economic research agencies.
Historical Context
This indicator is used by policymakers, investors, and financial analysts to evaluate the financial dynamics and potential investment opportunities within the pharmaceutical industry.
Key Facts
- Tracks non-standard long-term debt in pharmaceutical corporations
- Provides insights into sector-specific financial strategies
- Helps assess potential investment risks and opportunities
FAQs
Q: What does this economic indicator measure?
A: It measures long-term loans and debt obligations for U.S. pharmaceutical and medicine corporations that are due in more than one year.
Q: Why is this data important?
A: The data helps investors and analysts understand the financial health and borrowing patterns of the pharmaceutical sector.
Q: How often is this data updated?
A: The data is typically updated quarterly, providing a current snapshot of the sector's financial landscape.
Q: How can policymakers use this information?
A: Policymakers can assess sector financial trends, potential economic risks, and develop targeted economic strategies.
Q: What are the limitations of this indicator?
A: The data only covers specific types of long-term loans and does not include all forms of corporate debt or financing.
Related Trends
Contributions to the Chicago Fed Relative Midwest Economy Index: Illinois Contribution
RILINDEXM683SFRBCHI
Quarterly Financial Report: U.S. Corporations: Plastics and Rubber Products: Cash and Demand Deposits in the U.S.
QFR201326USNO
Quarterly Financial Report: U.S. Corporations: Communications Equipment: Income (Loss) Before Income Taxes
QFR111384USNO
Quarterly Financial Report: U.S. Corporations: Machinery: Total Assets
QFR223333USNO
Quarterly Financial Report: U.S. Corporations: Primary Metals: Total Cash on Hand and in U.S. Banks
QFRTCASHPRIUSNO
Quarterly Financial Report: U.S. Corporations: Telecommunications: All Other Noncurrent Assets
QFRD222517USNO
Citation
U.S. Federal Reserve, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Long-Term Debt, Due in More Than 1 Year: Other Long-Term Loans [QFRD319385USNO], retrieved from FRED.
Last Checked: 8/1/2025